Commentary: Sunlight, vitamin D, and the cancer connection revisited

International Journal of Epidemiology

Volumn 35, Issue 2, 2006, Pages 227-230

  Egan, Kathleen M ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; CALCIUM; VITAMIN D; VITAMIN D RECEPTOR;

CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; COLON CANCER; DIETARY INTAKE; ENVIRONMENTAL EXPOSURE; GEOGRAPHIC DISTRIBUTION; HUMAN; NOTE; NUTRITIONAL HEALTH; OBESITY; POPULATION DISTRIBUTION; PRIORITY JOURNAL; RADIATION EXPOSURE; RICKETS; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SUN EXPOSURE; SUNLIGHT; SURVIVAL RATE; ULTRAVIOLET RADIATION;

COLONIC NEOPLASMS; FEMALE; HUMANS; MALE; NEOPLASMS; SUNLIGHT; VITAMIN D;

EID: 33645825204     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyi263     Document Type: Note

References (46)

1. Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 1980;9:227-31.
2. (Reprinted Int J Epidemiol 2006;35:217-20.)
3. Holick MF. Photosynthesis of vitamin D in the skin: Effect of environmental and life-style variables. Fed Proc 1987;46: 1876-82.
4. Harris SS, Soteriades E, Coolidge JA, Mudgal S, Dawson-Hughes B. Vitamin D insufficiency and hyperparathyroidism in a low income, multiracial, elderly population. J Clin Endocrinol Metab 2000;85: 4125-30.
5. Semba RD, Garrett E, Johnson BA, Guralnik JM, Fried LP. Vitamin D deficiency among older women with and without disability. Am J Clin Nutr 2000;72:1529-34.
6. Nesby-O'Dell S, Scanlon KS, Cogswell ME et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: Third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 2002;76:187-92.
7. Mellanby E. Experimental Rickets. Medical research (G.B.), special report series SRS-61. London: His Majesty's Stationary Office, 1921, pp. 1-78.
8. Haussler MR, Myrtle JF, Norman AW. The association of a metabolite of vitamin D3 with intestinal mucosa chromatin in vivo. J Biol Chem 1968;243:4055-04.
9. Norman AW, Myrtle JF, Midgett RJ, Nowicki HG, Williams V, Popjak G. 1,25-dihydroxycholecalciferol: Identification of the proposed active form of vitamin D3 in the intestine. Science 1971;173:51-54.
10. Lawson DE, Fraser DR, Kodicek E, Morris HR, Williams DH. Identification of 1,25-dihydroxycholecalciferol, a new kidney hormone controlling calcium metabolism. Nature 1971;230: 228-30.
11. Holick MF, Schnoes HK, DeLuca HF. Identification of 1,25-dihydroxycholecalciferol, a form of vitamin D3 metabolically active in the intestine. Proc Natl Acad Sci USA 1971;68:803-04.
12. Haussler MR, Norman AW. Chromosomal receptor for a vitamin D metabolite. Proc Natl Acad Sci USA 1969;62:155-62.
13. Eisman JA, Martin TJ, MacIntyre I, Moseley JM. 1,25-dihydroxyvitamin-D-receptor in breast cancer cells. Lancet 1979;2:1335-36.
14. Abe E, Miyaura C, Sakagami H et al. Differentiation of mouse myeloid leukemia cells induced by 1 alpha, 25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 1981;78:4990-94
15. Available at: http://www.cpc.ncep.noaa.gov/products/stratosphere/ uv_index/uv_information.html
16. Devesa SS, Grauman MA, Blot WJ, Pennello GA, Hoover RN, Fraumeni JF. Atlas of Cancer Mortality in the United States, 1950 to 1994, NIH Publication No. 99-4564. Bethesda, MD: National Institutes of Health, 1999.
17. Grant WB, Holick MF. Benefits and requirements of vitamin D for optimal health: A review. Altern Med Rev 2005;10:94-111.
18. Leffell DJ, Brash DE. Sunlight and skin cancer. Sci Am 1996;275:52,53,56-59.
19. Apperly FL. The relation of solar radiation to cancer mortality in North America. Cancer Res 1941;1:191-95.
20. Darnton-Hill I, Darnton-Hill I, Nalubola R. Fortification strategies to meet micronutrient needs: Successes and failures. Proc Nutr Soc 2002;61:231-41.
21. Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: Implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005;135: 317-22.
22. Willett WC. Nutritional Epidemiology. 2nd Edn. New York: Oxford University Press, 1998.
23. Lamprecht SA, Lipkin M. Chemoprevention of colon cancer by calcium, vitamin D and folate: Molecular mechanisms. Nat Rev Cancer 2003;3:601-14.
24. Banerjee P, Chatterjee M. Antiproliferative role of vitamin D and its analogs - a brief overview. Mol Cell Biochem 2003;253:247-54.
25. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 2005;289:F8-28.
26. Ravid A, Koren R. The role of reactive oxygen species in the anticancer activity of vitamin D. Recent Results Cancer Res 2003;164: 357-67.
27. Chatterjee M. Vitamin D and genomic stability. Mutat Res 2001; 475:69-87.
28. Cantorna MT, Zhu Y, Froicu M, Wittke A. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 2004; 80 (6 Suppl):1717S-20S.
29. Hansen CM, Binderup L, Hamberg KJ, Carlberg C. Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogs on growth control and tumorigenesis. Front Biosci 2001;6:D820-48.
30. Robsahm TE, Tretli S, Dahlback A, Moan J. Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway).Cancer Causes Control 2004;15:149-58.
31. Garland C, Shekelle RE, Barrett-Connor E, Criqui MH, Rossof AH, Paul O. Dietary vitamin D and calcium and risk of colorectal cancer: A 19-year prospective study in men. Lancet 1985;1: 307-09.
32. Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK, Gorham ED. Serum 25-hydroxyvitamin D and colon cancer: Eight-year prospective study. Lancet 1989;2:1176-78.
33. Lefkowitz ES, Garland CF. Sunlight, vitamin D, and ovarian cancer mortality rates in US women. Int J Epidemiol 1994;23: 1133-36.
34. Garland FC, Garland CF, Gorham ED, Young JF. Geographic variation in breast cancer mortality in the United States: A hypothesis involving exposure to solar radiation. Prev Med 1990;19:614-22.
35. Gorham ED, Garland FC, Garland CF. Sunlight and breast cancer incidence in the USSR. Int J Epidemiol 1990;19:820-24.
36. Rodriguez G. New insights regarding pharmacologic approaches for ovarian cancer prevention. Hematol Oncol Clin North Am 2003;17:1007-20, x.
37. Welsh J. Vitamin D and breast cancer: Insights from animal models. Am J Clin Nutr 2004;80(6 Suppl):1721S-4S.
38. Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: A review (United States). Cancer Causes Control 2005; 16:83-95.
39. Garland FC, White MR, Garland CF, Shaw E, Gorham ED. Occupational sunlight exposure and melanoma in the U.S. Navy. Arch Environ Health 1990;45:261-67.
40. Berwick M, Armstrong BK, Ben-Porat L et al. Sun exposure and mortality from melanoma. J Natl Cancer Inst 2005;97:195-99.
41. Millen AE, Tucker MA, Hartge P et al. Diet and melanoma in a case-control study. Cancer Epidemiol Biomarkers Prev 2004;13: 1042-51.
42. Grant WB, Garland CF. A critical review of studies on vitamin D in relation to colorectal cancer. Nutr Cancer 2004;48:115-23.
43. Grant WB. Ecologic studies of solar UV-B radiation and cancer mortality rates. Recent Results Cancer Res 2003;164:371-77.
44. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-38.
45. Grant WB, Garland CF, Holick MF. Comparisons of estimated economic burdens due to insufficient solar ultraviolet irradiance and vitamin D and excess solar UV irradiance for the United States. Photochem Photobiol 2005; doi:10.1562/2005-01-24-RA-424.
46. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004;80(6 Suppl):1678S-88S.